US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

GLUCOSAMINE/CHONDROITIN Capsule

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling:Label Mixup; GLUCOSAMINE/CHONDROITIN Capsule, 500 mg/400 mg may be potentially mislabeled as FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD60240_30, EXP: 5/22/2014.

What was recalled

GLUCOSAMINE/CHONDROITIN Capsule, 500 mg/400 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 54458010022

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-616-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glucosamine recalls

See all
Class II · Moderate risk Terminated

Artridon Glucosamine

Reason CGMP Deviations

Kenil Healthcare Private Limited NDC 55758-030-05 D-0421-2025
Class II · Moderate risk Ongoing

Glucosamine 200 mg/mL

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0258-2017
Class II · Moderate risk Terminated

Glucosamine HCL Injectable

Reason Lack of Assurance of Sterility

Downing Labs, LLC D-0352-2016
Class II · Moderate risk Terminated

Glucosamine/Chondroitin Ds

Reason Labeling: Label Mixup; GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD60211_11, EXP: 5/22/2014.

Aidapak Services, LLC D-484-2014